XML 112 R96.htm IDEA: XBRL DOCUMENT v3.19.1
Employee and Non-Employee Director Stock and Benefit Plans - Share Awards (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 15, 2019
$ / shares
shares
May 27, 2016
USD ($)
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
installment
item
$ / shares
shares
Employee and non-employee director stock and benefit plans          
Common Stock, Par or Stated Value Per Share | $ / shares     $ 0.01 $ 0.01  
Common Class A [Member]          
Employee and non-employee director stock and benefit plans          
Trading days based on which volume-weighted average price per share is calculated     10 days    
Common Class A [Member] | Virtu Financial [Member]          
Employee and non-employee director stock and benefit plans          
Common Stock, Par or Stated Value Per Share | $ / shares     $ 0.00001    
Chief Executive Officer          
Employee and non-employee director stock and benefit plans          
Number of Inducement Awards granted | item         2
Restricted share awards          
Total Number of Shares          
Outstanding at the beginning of the period (in shares)     2,907,545 3,063,264 3,171,036
Granted (in shares)     1,307,357 1,259,392 1,665,916
Vested (in shares)     (1,277,549) (1,331,021) (1,042,238)
Forfeited (in shares)     (257,099) (84,090) (731,450)
Outstanding at the end of the period (in shares)     2,680,254 2,907,545 3,063,264
Weighted Average Grant Date Fair Value          
Outstanding at the beginning of the period (in dollars per share) | $ / shares     $ 18.10 $ 16.63 $ 16.75
Granted (in dollars per share) | $ / shares     21.18 19.81 16.16
Vested (in dollars per share) | $ / shares     18.84 16.60 16.06
Forfeited (in dollars per share) | $ / shares     19.35 18.99 16.88
Outstanding at the end of the period (in dollars per share) | $ / shares     $ 19.50 $ 18.10 $ 16.63
Additional disclosures          
Number of unvested shares converted into vested shares upon divestiture     1,277,549 1,331,021 1,042,238
Unrecognized compensation costs | $     $ 25.2    
Weighted average period over which unrecognized compensation costs are expected to be recognized     1 year 2 months 12 days    
Grant date fair value | $     $ 23.9    
Tax benefits related to the vesting | $     0.6 $ 1.5 $ 0.8
Tax shortfalls | $     0.1 0.1 0.7
Share-based compensation expense | $     28.4 19.6 24.9
Tax benefit related to share-based compensation expense | $     $ 1.2 $ 0.9 $ 8.9
ROE-Based Market Based Or Performance Based          
Total Number of Shares          
Outstanding at the beginning of the period (in shares)     393,344 342,370 377,475
Granted (in shares)     122,424 140,796 228,895
Vested (in shares)     (45,065) (51,498) (73,243)
Forfeited (in shares)     (144,715) (38,324) (190,757)
Outstanding at the end of the period (in shares)     325,988 393,344 342,370
Additional disclosures          
Number of unvested shares converted into vested shares upon divestiture     45,065 51,498 73,243
Performance-based share awards          
Total Number of Shares          
Outstanding at the end of the period (in shares)     263,220    
Market-based share awards          
Total Number of Shares          
Outstanding at the end of the period (in shares)     62,768    
Time-Based Restricted Stock Units          
Total Number of Shares          
Outstanding at the beginning of the period (in shares)     2,514,201 2,720,894 2,793,561
Granted (in shares)     1,184,933 1,118,596 1,437,021
Vested (in shares)     (1,232,484) (1,279,523) (968,995)
Forfeited (in shares)     (112,384) (45,766) (540,693)
Outstanding at the end of the period (in shares)     2,354,266 2,514,201 2,720,894
Additional disclosures          
Number of unvested shares converted into vested shares upon divestiture     1,232,484 1,279,523 968,995
Restricted Stock, Inducement Awards, Tranche One [Member] | Chief Executive Officer          
Total Number of Shares          
Granted (in shares)         135,353
Additional disclosures          
Number of equal annual vesting installments | installment         3
Restricted Stock, Inducement Awards, Tranche Two [Member] | Chief Executive Officer          
Total Number of Shares          
Granted (in shares)         156,051
Restricted Stock, Inducement Awards, Tranche Two [Member] | Chief Executive Officer | Vesting on January 31, 2016          
Additional disclosures          
Vesting percent         38.00%
Vesting period         12 months
Restricted Stock, Inducement Awards, Tranche Two [Member] | Chief Executive Officer | Vesting on January 31, 2017          
Additional disclosures          
Vesting percent         41.00%
Restricted Stock, Inducement Awards, Tranche Two [Member] | Chief Executive Officer | Vesting on January 31, 2018          
Additional disclosures          
Vesting percent         21.00%
Phantom share awards          
Total Number of Shares          
Outstanding at the beginning of the period (in shares)       0 57,798
Granted (in shares)     0 0  
Vested (in shares)         (57,798)
Outstanding at the end of the period (in shares)     0   0
Weighted Average Grant Date Fair Value          
Outstanding at the beginning of the period (in dollars per share) | $ / shares         $ 12.24
Vested (in dollars per share) | $ / shares         $ 12.24
Additional disclosures          
Number of unvested shares converted into vested shares upon divestiture         57,798
Stock options          
Employee and non-employee director stock and benefit plans          
Exercise price (in dollars per share) | $ / shares     $ 16.18   $ 12.17
Additional disclosures          
Share-based compensation expense | $     $ 1.1 $ 0.3 $ 0.3
Tax benefit related to share-based compensation expense | $     $ 0.0 0.0 $ 0.1
2007 Plan | Restricted share awards | Vesting on January 31, 2017          
Additional disclosures          
Vesting percent     33.33%    
2007 Plan | Restricted share awards | Vesting on January 31, 2018          
Additional disclosures          
Vesting percent     66.67%    
2007 Plan | Phantom share awards          
Additional disclosures          
Share-based compensation expense | $       0.1  
Tax benefit related to share-based compensation expense | $       $ 0.1  
Sale of subsidiaries | ITG Investment Research | Restricted share awards          
Total Number of Shares          
Vested (in shares)   (226,802)      
Additional disclosures          
Number of unvested shares converted into vested shares upon divestiture   226,802      
Cost to modify the vesting schedule | $   $ 0.7      
Subsequent event | Stock options          
Employee and non-employee director stock and benefit plans          
Accelerated vesting 65,611        
Exercise price (in dollars per share) | $ / shares $ 16.18